BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38443608)

  • 1. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.
    Wong JC; Zhang Y; Lieuw KH; Tran MT; Forgo E; Weinfurtner K; Alzamora P; Kogan SC; Akagi K; Wolff L; Le Beau MM; Killeen N; Shannon K
    Blood; 2010 Jun; 115(22):4524-32. PubMed ID: 20233966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
    McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
    Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
    El-Menoufy MAM; Mourad ZI; Farahat NM
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
    Hosono N
    Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.
    Wong JC; Weinfurtner KM; Westover T; Kim J; Lebish EJ; Del Pilar Alzamora M; Huang BJ; Walsh M; Abdelhamed S; Ma J; Klco JM; Shannon K
    Leukemia; 2024 May; 38(5):1182-1186. PubMed ID: 38443608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of CUX1 and chromosome 7 in myeloid malignancies.
    Jotte MRM; McNerney ME
    Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enigma of monosomy 7.
    Inaba T; Honda H; Matsui H
    Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of chromosome 7 abnormalities in myeloid malignancies].
    Shi WH; Li X; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1739-43. PubMed ID: 25543507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. -7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.
    Honda H; Nagamachi A; Inaba T
    Oncogene; 2015 May; 34(19):2413-25. PubMed ID: 24998854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosomy 7 predisposes to diabetes insipidus in leukaemia and myelodysplastic syndrome.
    de la Chapelle A; Lahtinen R
    Eur J Haematol; 1987 Nov; 39(5):404-11. PubMed ID: 3319680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monosomy 7: recent progress].
    Inaba T; Nagamachi A
    Rinsho Ketsueki; 2019; 60(9):1020-1026. PubMed ID: 31597823
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.